Ontology highlight
ABSTRACT: Objective
The mechanisms through which ω-3 fatty acids reduce adverse cardiac events remain uncertain. We aimed to investigate the effect of ω-3 fatty acid supplementation on endothelial vasomotor function, endogenous fibrinolysis, and platelet and monocyte activation in patients with coronary heart disease.Design
Randomised, double-blind, placebo-controlled, cross-over trial.Setting
Academic cardiac centre.Participants
20 male patients with a previous myocardial infarction.Intervention
ω-3 Fatty acid supplementation (2 g/day for 6 weeks) versus olive oil placebo.Outcome measures
Peripheral blood was taken for analysis of platelet and monocyte activation, and forearm blood flow (FBF) was assessed in a subset of 12 patients during intrabrachia
SUBMITTER: Din JN
PROVIDER: S-EPMC3787492 | biostudies-literature | 2013 Sep
REPOSITORIES: biostudies-literature